Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun An atypical antipsychotic under development for the treatment of schizophrenia and acute mania associated with bipolar disorder.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word asenapine.

Examples

  • The Food and Drug Administration gave final approval to Schering-Plough Corp. 's asenapine, a treatment for both schizophrenia and bipolar disorder in adults.

    FDA OKs Schering-Plough Drug for Schizophrenia, Bipolar

  • In addition to the two companies 'currently marketed neuroscience products, Schering-Plough brings several promising late-stage candidates, including SAPHRIS (asenapine), an antipsychotic drug for the treatment of schizophrenia and bipolar disorder, and BRIDION (suggamadex), a novel anesthesia reversal agent.

    Merck, Schering-Plough Statement

  • "We see growth of the CNS central nervous system division driven by Lyrica, Geodon, as well as Indiplon, vareniclin, and asenapine."

    Pfizer Seen With Two Drug Approvals In May

  • Haloperidol also had the highest number of significant differences in head-to-head comparisons, coming out better than Otsuka Pharmaceutical's Abilify, known generically as aripiprazole; carbamazepine, sold as Carbatrol by Shire and Tegretol by Novartis; valproate, sold by Abbott Laboratories as Depakine and Sanofi-Aventis as Epilim; Lundbeck's and Merck's asenapine.

    Reuters: Press Release

  • SAPHRIS (asenapine), Merck's sublingual tablet for acute treatment of schizophrenia in adults and acute treatment of manic or mixed episodes associated with bipolar I disorder, was approved for use in the United States during the third quarter of 2009 and a full launch is under way.

    THE MEDICAL NEWS

  • The application for asenapine is also under review in the EU.

    THE MEDICAL NEWS

  • SAPHRIS (asenapine), Merck's sublingual tablet for acute treatment of schizophrenia in adults and acute treatment of manic or mixed episodes associated with bipolar I disorder, was approved for use in the United States during the third quarter of 2009 and a full launch is under way.

    WebWire | Recent Headlines

  • SAPHRIS (asenapine), Merck's sublingual tablet for acute treatment of schizophrenia in adults and acute treatment of manic or mixed episodes associated with bipolar I disorder, was approved for use in the United States during the third quarter of 2009 and a full launch is under way.

    THE MEDICAL NEWS

  • The application for asenapine is also under review in the EU.

    WebWire | Recent Headlines

  • The application for asenapine is also under review in the EU.

    THE MEDICAL NEWS

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.